STUB1 and atrial fibrillation: Early detection of CHIP mutations could enable clinicians to implement targeted monitoring and interventions aimed at slowing AF progression, such as advanced imaging to assess atrial remodeling, more aggressive rhythm control strategies, earlier referral for catheter ablation, and optimized anticoagulation to mitigate thromboembolic risk.